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We read with great interest the study by Priano titled “Early
efficacy of intra-articular HYADD® 4 (Hymovis®) injections
for symptomatic knee osteoarthritis.”1 The author would like
to explore the efficacy of intra-articular HYADD 4 (Hymovis)
injections for symptomatic knee osteoarthritis. Results from
this study are very interesting and promising from a clinical
aspect; however, we believe that studying patient’s clinical
status with visual analog scale and Western Ontario and
McMaster Universities Arthritis Index scale should be sup-
ported by biomechanical information. From this point of
view, to have more data that could influence the clinical
practice, it is important to note the possible action that intra-
articular injections of different kinds of hyaluronic acid could
have on walking biomechanics using an objective measure-
ment tool as gait analysis. In our opinion, thework by Priano1
is promising because it investigates the efficacy of a new
formulation of hyaluronic acid. Nowadays, many hyaluronic
acid formulations are approved for clinical use in Europe and
the United States. Furthermore, hyaluronic acid injections’
efficacy has been demonstrated also in hip osteoarthritis.2
However, even if these formulations differ in their chemical–
physical properties, joint space half-life, rheological proper-
ties, and clinical efficacy, there are few studies that investi-
gate hyaluronic acid’s possible action from a biomechanical
point of view.3,4 From this point of view, we believe that
osteoarthritis management and rehabilitation should be
prescribed after an objective analysis of functional walking
alterations using gait analysis instrumentations. The use
of gait analysis should be desirable during diagnosis and
follow-up. In fact, it is capable to identify different walking
patterns in patient with osteoarthritis of the lower limbs,
whereas the radiology can evaluate the status of the joint’s
structures. Moreover, gait analysis can find the exact altered
phase of the walking cycle, guaranteeing a precise prescrip-
Fig. 1 Knee flexion–extension kinematic.
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tion of a rehabilitation program, giving the clinician data
about spatial–temporal parameters, kinematic and kinetic
alterations, and about the surface electrical muscle activity
using surface electromyography. In conclusion, gait analysis
is easily applicable to most of the patients, without side
effects. Hence, this instrumentation is suitable for follow-up
evaluations and permits to assess any variations of walking
biomechanics over time.
As an example, we would like to present a case of a patient
(female, 42years old) affectedbykneeosteoarthritis (II grade—
Kellgren and Lawrence classification), treated with two intra-
articular injection of mobile reticulum hyaluronic acid, eval-
uated with gait analysis before treatment and 6 months after
the treatment. In our patients is evident the improvement of
the flexion–extension kinematic as a consequence of the
treatment performed, inparticular,wewould like to underline
the amelioration of the first flexion peak at the loading
response phase of the walking cycle (►Fig. 1). Finally, we
would like to underline howgait analysis could represent very
important outcomemeasurement to determinate the efficacy
of intra-articular injection therapy to treat knee osteoarthritis.
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